BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29654696)

  • 1. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.
    Thorlacius L; Ingram JR; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Nielsen SM; Christensen R; Garg A; Jemec GBE;
    Br J Dermatol; 2018 Sep; 179(3):642-650. PubMed ID: 29654696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.
    Thorlacius L; Ingram JR; Garg A; Villumsen B; Esmann S; Kirby JS; Gottlieb AB; Merola JF; Dellavalle R; Christensen R; Jemec GB
    BMJ Open; 2017 Feb; 7(2):e014733. PubMed ID: 28219961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II.
    Thorlacius L; Garg A; Ingram JR; Villumsen B; Theut Riis P; Gottlieb AB; Merola JF; Dellavalle R; Ardon C; Baba R; Bechara FG; Cohen AD; Daham N; Davis M; Emtestam L; Fernández-Peñas P; Filippelli M; Gibbons A; Grant T; Guilbault S; Gulliver S; Harris C; Harvent C; Houston K; Kirby JS; Matusiak L; Mehdizadeh A; Mojica T; Okun M; Orgill D; Pallack L; Parks-Miller A; Prens EP; Randell S; Rogers C; Rosen CF; Choon SE; van der Zee HH; Christensen R; Jemec GBE
    Br J Dermatol; 2018 Mar; 178(3):715-721. PubMed ID: 29080368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
    Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
    JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
    Wainman HE; Chandran NS; Frew JW; Garg A; Gibbons A; Gierbolini A; Horvath B; Jemec GB; Kirby B; Kirby J; Lowes MA; Martorell A; McGrath BM; Naik HB; Oon HH; Prens E; Sayed CJ; Thorlacius L; Van der Zee HH; Villumsen B; Ingram JR
    Br J Dermatol; 2024 Mar; 190(4):510-518. PubMed ID: 37976235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice: A HiSTORIC Consensus Statement.
    Mastacouris N; Tannenbaum R; Strunk A; Koptyev J; Aarts P; Alhusayen R; Bechara FG; Benhadou F; Bettoli V; Brassard A; Brown D; Choon SE; Coutts P; da Silva DLF; Daveluy S; Dellavalle RP; Del Marmol V; Emtestam L; Gebauer K; George R; Giamarellos-Bourboulis EJ; Goldfarb N; Hamzavi I; Hazen PG; Horváth B; Hsiao J; Ingram JR; Jemec GBE; Kirby JS; Lowes MA; Marzano AV; Matusiak L; Naik HB; Okun MM; Oon HH; Orenstein LAV; Paek SY; Pascual JC; Fernandez-Peñas P; Resnik BI; Sayed CJ; Thorlacius L; van der Zee HH; van Straalen KR; Garg A
    JAMA Dermatol; 2023 Nov; 159(11):1258-1266. PubMed ID: 37755725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
    Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
    Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals.
    van Tol RR; Kimman ML; Melenhorst J; Stassen LPS; Dirksen CD; Breukink SO;
    Colorectal Dis; 2019 May; 21(5):570-580. PubMed ID: 30628177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
    Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Trials; 2014 Dec; 15():511. PubMed ID: 25540987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core outcome domains for clinical trials in non-specific low back pain.
    Chiarotto A; Deyo RA; Terwee CB; Boers M; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Lin CW; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Eur Spine J; 2015 Jun; 24(6):1127-42. PubMed ID: 25841358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative.
    Jacobson ME; Rick JW; Gerbens LAA; Baghoomian W; Gould LJ; Marzano AV; Chen DM; Oakes DL; Dissemond J; Yamamoto T; Shinkai K; Nolan B; Lobato D; Thomas KS; Ortega-Loayza AG;
    Br J Dermatol; 2024 Feb; 190(3):392-401. PubMed ID: 37952167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expert consensus on priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa: a Delphi consensus study.
    Yamanaka-Takaichi M; Revankar R; Shih T; Gall M; Hsiao JL; Shi VY; Alavi A
    Arch Dermatol Res; 2023 Sep; 315(7):2129-2136. PubMed ID: 36951970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary.
    Frew JW; Lowes MA; Goldfarb N; Butt M; Piguet V; O'Brien E; Ingram J; Jemec GBE; Tan J; Zouboulis C; Alavi A; Kirby JS
    JAMA Dermatol; 2021 Apr; 157(4):449-455. PubMed ID: 33688910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of core outcome sets in hidradenitis suppurativa: systematic review of outcome measure instruments to inform the process.
    Ingram JR; Hadjieconomou S; Piguet V
    Br J Dermatol; 2016 Aug; 175(2):263-72. PubMed ID: 26873867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core Outcome Set for IgE-mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study 'COMFA'.
    Demidova A; Drewitz KP; Kimkool P; Banjanin N; Barzylovich V; Botjes E; Capper I; Castor MAR; Comberiati P; Cook EE; Costa J; Chu DK; Epstein MM; Galvin AD; Giovannini M; Girard F; Golding MA; Greenhawt M; Ierodiakonou D; Jones CJ; Khaleva E; Knibb RC; Macit-Çelebi MS; Mack DP; Mafra I; Marchisotto MJ; Mijakoski D; Nekliudov N; Özdemir C; Patel N; Pazukhina E; Protudjer JLP; Rodríguez Del Rio P; Roomet J; Sammut P; Schoos AM; Schopfer AF; Schultz F; Seylanova N; Skypala I; Sørensen M; Stoleski S; Stylianou E; Upton J; van de Veen W; Genuneit J; Boyle RJ; Apfelbacher C; Munblit D;
    Allergy; 2024 Apr; 79(4):977-989. PubMed ID: 38433402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments and new assessment instruments for Hidradenitis suppurativa.
    van Straalen KR; Ingram JR; Augustin M; Zouboulis CC
    Exp Dermatol; 2022 Sep; 31 Suppl 1(Suppl 1):33-39. PubMed ID: 35582833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document.
    Alavi A; Lynde C; Alhusayen R; Bourcier M; Delorme I; George R; Gooderham M; Gulliver W; Kalia S; Marcoux D; Poulin Y
    J Cutan Med Surg; 2017; 21(6):513-524. PubMed ID: 28639459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a core outcome set for use in community-based bipolar trials-A qualitative study and modified Delphi.
    Retzer A; Sayers R; Pinfold V; Gibson J; Keeley T; Taylor G; Plappert H; Gibbons B; Huxley P; Mathers J; Birchwood M; Calvert M
    PLoS One; 2020; 15(10):e0240518. PubMed ID: 33112874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.